Around the world, 350 million people suffer from a depressive-related disorder, costing patients big dollars for treatment.
SSRIs, a traditional class of antidepressants, make up the greater number of prescriptions for depression and anxiety disorders. But new research may soon change that.
Magnesium, generally found over-the-counter, might help improve symptoms of mild to moderate depression, according to a study published in PLoS One.
The study began by examining 126 outpatient adults, who were experiencing low to moderate symptoms of depression at the time; the average age was 58, and about 38 percent were male. Emily Tarleton, a clinical research manager, and her colleagues initiated the study.
Over a six week period, the first set of participants took 248 milligrams of magnesium through oral administration. Meanwhile, the second set of participants received no treatment whatsoever.
Symptoms of depression were monitored on a two-week basis, documenting mood, appetite, and thought patterns.
Out of the 112 participants with sufficient data to analyze, researchers noticed a ‘clinically significant improvement’ in symptoms of both depression and anxiety, when compared to those with no treatment.
The unusual changes in mood and behavior occurred within two weeks of using magnesium, with all participants reporting well-tolerance despite gender or age.
The new clinical trials of mineral magnesium are giving researchers more insight into its true effectiveness in treating depressive symptoms.
By the end of the study, Tarleton and her team quickly noticed that magnesium might be as useful as SSRI antidepressants.
The study, although a first in magnesium testing, brought dramatic insight into a well-known hypothesis that remained in the dark for so long. And it probably won’t be the last, so stock up on magnesium.